Glucose metabolism in patients with neurological/neuromuscular diseases.
- Conditions
- Patients with neurological/neuromuscular diseases
- Registration Number
- EUCTR2006-004749-40-BE
- Lead Sponsor
- Pediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Spina bifida (age 8 - adult age) + insuline resistance or fat mass > 30%
Duchenne muscular dystrophy (age 8 - adult age) + insuline resistance or fat mass >30%
SMA (age 8 - adult age) + insuline resistance or fat mass >30%
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
renal failure
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: prevalence of impaired glucose tolerance and cardiovascular risk factors.<br>Evaluate effect of treatment with Metformin.;Secondary Objective: ;Primary end point(s): Oral glucose tolerance test<br>Dexa sca
- Secondary Outcome Measures
Name Time Method